Glycolic Acid from Biomass: A Sustainable Route to High-Purity AHA

Glycolic acid (GA) is a high-demand α-hydroxy acid used in cosmetics, cleaners, biodegradable polymers, and drug delivery systems. Traditionally made from fossil-based formaldehyde or chloroacetic acid, the production is energy-intensive and toxic. A bio-based approach using microbial or catalytic conversion of sugars or agro-waste offers a safer, sustainable alternative.

This blog explores the pathway to bio-based glycolic acid, showcases key startups, outlines commercialization progress, and evaluates challenges to scale-up.

How Biomass Enables Bio-Glycolic Acid Production

Pathways (Condensed, Point-Based):

• Microbial Fermentation:
  Engineered E. coli, Corynebacterium, or yeast produce GA via the glyoxylate shunt, using enzymes like glycolate oxidase, glyoxylate reductase, and aldehyde dehydrogenase. Substrates: glucose, xylose.
• Catalytic Oxidation:
  Heterogeneous catalysts (Pt, Mo, Au/C) convert C6 or C5 sugars into GA in aqueous-phase reactions. Can integrate with biorefinery streams.
• C1-Based Routes (Emerging):
  Lab-stage technologies convert CO₂ or syngas into GA via synthetic biology or electrocatalysis.

Case Study: CrossChem (Japan)

Highlights:

• Fermentation-based process for natural-grade GA
• Avoids formaldehyde and petrochemical intermediates
• Certified for use in clean-label and ECOCERT cosmetics

Timeline:

• 2016: Lab-scale production initiated
• 2019: Pilot scale achieved; sample validation for skincare
• 2022: Commercial launch in Japan and EU markets

Case Study: ChainCraft (Netherlands)

Highlights:

• Converts organic waste streams to fatty acids and short-chain molecules including glycolic acid
• Uses mixed-culture fermentation, scalable and waste-integrated
• Focuses on food-grade and biopolymer applications

Timeline:

• 2017: Pilot-scale demo facility operational
• 2021: Scale-up supported by EU Horizon funding
• 2023: Glycolic acid integrated into product pipeline

Global Startups Working on Bio-Glycolic Acid

• Capra Biosciences (USA)
  Developing modular bioreactors for organic acid production, including glycolic acid from renewable alcohols and sugars
• Locus Performance Ingredients (USA)
  Focused on bio-surfactants and glycolic acid derivatives from fermentation-based platforms
• BioC3 (Germany)
  Works on electrocatalytic production of glycolic acid from CO₂, in pre-pilot phase

India’s Position

India currently lacks startups focused exclusively on glycolic acid. However:

• Strong fermentation R&D in NIIST, ICT Mumbai, and BIRAC-funded biofoundries
• Biorefinery waste streams (bagasse, molasses) offer feedstock potential
• Bio-based GA aligns with India’s natural cosmetics and bioplastics initiatives
  Future pathways could emerge under DBT-BIRAC’s BioFoundry and BioE3 programs.

Commercialization Outlook

Market and Demand

• Global glycolic acid market was ~$330M in 2023, projected to reach $500M+ by 2030
• Key demand drivers:
• Cosmetics & skincare (AHA exfoliants, peels)
• Biodegradable polymers (PLA-GA copolymers)
• Cleaning agents and chelators
• 60–70% demand from cosmetics & personal care

Key Drivers

• Shift to natural-label skincare and certified ingredients
• Push for fossil-free chemical inputs in Europe
• Strong interest in biodegradable PLA-GA copolymers

Challenges to Address

1. Fermentation Titers and Yields

• Current engineered strains deliver 10–30 g/L, still below industrial standards
• Side-products like oxalate complicate purification

2. Separation and Purification

• GA is highly water-soluble and forms azeotropes
• Requires multi-step extraction or ion exchange, raising costs

3. Process Economics

• Bio-GA costs ~$4–5/kg, vs fossil GA at $2.5–3.5/kg
• CAPEX for bioprocessing plants remains high in absence of co-product valorization

4. Regulatory Barriers

• Pharma and cosmetic applications demand low endotoxin, high-purity
• Bio-based certification adds time and compliance costs

Progress Indicators

• 2014–2016: First reports of engineered E. coli for GA via glyoxylate shunt
• 2017–2019: Jungbunzlauer files patent on GA from glucose
• 2019: ChainCraft pilot launched for waste-to-acid platform
• 2022: CrossChem’s cosmetic-grade GA enters EU and Japan markets
• 2024: GA appears in COSMOS-certified product lines; demand surges for natural AHAs

Technology Readiness Level (TRL)

TRL: 6–8
Bio-based glycolic acid has reached pilot and commercial scales in cosmetics and industrial applications, with polymer applications still in early rollout phase.

Conclusion

Bio-based glycolic acid is becoming a compelling alternative to fossil-based routes, especially for cosmetics, biodegradable plastics, and industrial cleaners. Innovations in fermentation and waste valorization by startups like CrossChem, ChainCraft, and Capra Biosciences show scalability and market acceptance. Though India has no direct commercial player yet, the country’s feedstock availability, fermentation R&D, and demand for natural ingredients place it in a strong position to enter the space. As cost curves decline and purity improves, bio-GA is set to establish itself as a core building block of the green chemical economy.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in